Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$14.73
Market cap
$3.79B
P/E Ratio
2.91
Dividend/share
$1.12
EPS
$5.07
Enterprise value
$11.78B
Highlights
The equity has soared by 184% YoY
Organon's net income has soared by 122% YoY and by 30% from the previous quarter
The gross margin has contracted by 3.8% YoY
Key stats
What are the main financial stats of OGN
Market
Valuations
Earnings
Shares outstanding
257.54M
Market cap
$3.79B
Enterprise value
$11.78B
Price to book (P/B)
7.69
Price to sales (P/S)
0.59
EV/EBIT
9.07
EV/EBITDA
7.56
EV/Sales
1.84
Revenue
$6.41B
Gross profit
$3.73B
Net income
$1.3B
EBIT
$1.3B
EBITDA
$1.56B
Free cash flow
$749M
Per share
Balance sheet
Liquidity
EPS
$5.07
EPS diluted
$5.04
Free cash flow per share
$2.91
Book value per share
$1.91
Revenue per share
$24.89
TBVPS
$28.68
Total assets
$12.75B
Total liabilities
$12.26B
Debt
$8.75B
Equity
$493M
Working capital
$1.97B
Debt to equity
17.75
Current ratio
1.7
Quick ratio
0.88
Net debt/EBITDA
5.12
Margins
Efficiency
Dividend
EBITDA margin
24.3%
Gross margin
58.3%
Net margin
20.3%
Operating margin
20.8%
Return on assets
10.7%
Return on equity
846.2%
Return on invested capital
10.6%
Return on capital employed
13%
Return on sales
20.3%
Dividend yield
7.6%
DPS
$1.12
Payout ratio
22.1%
OGN stock price
How has the Organon stock price performed over time
Intraday
0.2%
1 week
-0.27%
1 month
-3.6%
1 year
5.9%
YTD
2.15%
QTD
-23%
Financial performance
How have Organon's revenue and profit performed over time
Revenue
$6.41B
Gross profit
$3.73B
Operating income
$1.33B
Net income
$1.3B
Gross margin
58.3%
Net margin
20.3%
Organon's net income has soared by 122% YoY and by 30% from the previous quarter
Organon's net margin has soared by 114% YoY and by 28% from the previous quarter
The company's operating income rose by 9% QoQ and by 6% YoY
OGN's operating margin is up by 8% since the previous quarter
Growth
What is Organon's growth rate over time
Valuation
What is Organon stock price valuation
P/E
2.91
P/B
7.69
P/S
0.59
EV/EBIT
9.07
EV/EBITDA
7.56
EV/Sales
1.84
The company's EPS has surged by 120% YoY and by 30% QoQ
The price to earnings (P/E) is 32% less than the last 4 quarters average of 4.3
The equity has soared by 184% YoY
The price to sales (P/S) is 16% lower than the last 4 quarters average of 0.7
The revenue has increased by 4.2% year-on-year
Efficiency
How efficient is Organon business performance
The ROA has soared by 98% year-on-year and by 26% since the previous quarter
The company's return on sales rose by 9% QoQ and by 4.1% YoY
The return on invested capital is up by 7% since the previous quarter
Dividends
What is OGN's dividend history
DPS
$1.12
Dividend yield
7.6%
Payout ratio
22.1%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Organon financials performed over time
OGN's total assets is 4% more than its total liabilities
OGN's total assets is up by 16% YoY and by 4.9% from the previous quarter
OGN's total liabilities is up by 6% year-on-year and by 2.1% since the previous quarter
The equity has soared by 184% YoY
The debt to equity has plunged by 70% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.